NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the UBS Tenth Annual Global Life Sciences Conference on Monday, September 21, 2009, at 8:30 AM ET at the Grand Hyatt in New York City.
